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1. INTRODUCTION  
 
1.1. Sodium-D-Glucose Cotransporter SGLT1 
 
The life of every organism depends on the continuous supply of energy. One of the 
most important metabolic fuels is D-glucose. In mammals, glucose transport is 
mediated by a number of integral membrane proteins known as specific carriers. They 
are involved in the absorption of glucose through the proximal tubular segment of the 
nephron and intestinal epithelial cells. The glucose is returned to the circulation to 
maintain its blood levels and to provide other cells with a source of energy for various 
metabolic requirements (Hirayama et al., 1997; Loo et al., 1998). At present about 
five facilitated-diffusion glucose transporters (GLUT-1 to GLUT-4 and GLUT-7) are 
believed to exist in mammalian cells. In addition, sodium glucose cotransporters 
(SGLTs) are known to be involved in glucose uptake (Loo et al., 1998; Vayro et al., 
1998). Members of the sodium/glucose cotransporter family are found throughout the 
living organisms as they transport a wide variety of substrates (sugars, inositol, iodide, 
urea and proline) into the cell using the electrochemical gradient of cations like Na+, 
Li+, or H+ (Veenstra et al., 2002; Michael et al., 2000; Turk & Wright, 1997; Wright 
et al., 1998; Wright, 2001). For example, the extent of Na+ - dependent glucose 
absorption is dependent upon SGLT1 protein content (Fringes et al., 2001; Murer et 
al., 1974; Beck and Sacktor, 1975). The SGLT1 is a high-affinity glucose transporter 
(Km ~100 µM; Wright, 1993) that couples glucose transport into the cell to an 
inwardly directed Na+ gradient (Figure 1.1). This Na+ gradient is maintained by 
Na+/K+-ATPase in the basolateral membrane. The stoichiometry of the process 
dictates that two Na+ cross the membrane with each glucose molecule. SGLT1 has 
been demonstrated to transport in addition 210 water molecules along with each 
glucose (Meinild et al., 1998). 
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FIG. 1.1. Glucose transport in enterocytes. The Na+-dependent glucose transporter 
(SGLT1) is located in the apical membrane and transports Na+ (two) coupled with glucose or 
galactose and water. This transport is driven by the inwardly directed Na+ gradient, which is 
maintained by the activity of Na+/K+-ATPase in the basolateral membrane. The facilitative 
transporter GLUT2 transports sugars across the basolateral membrane, whereas the 
facilitative transporter GLUT5 transports fructose across the apical membrane (adapted from 
Wright, 1993). 
 
 
 
Coupling of glucose, sodium flux and translocation of the compounds are supposed to 
be accompanied by conformational changes of the protein. Such changes could be 
induced for example by Na+, which increases the cotransporter’s affinity for sugar 
(Panayotova et al., 1997; Lo and Silverman, 1998). Mutagenesis studies revealed that 
the N-terminal half of the peptide contains the Na+ binding sites, as amino acids 162-
173 apparently constitute a part of an external Na+ pore in the SGLT1 peptide, while 
glucose binds and permeates through the C-terminal half of the cotransporter since 
Gln 457 and Thr 460 control sugar-binding (Diez-Sampedro et al., 2001; Diedrich, 
1966; Oulianova et al., 2001; Oulianova and Berteloot, 1996). It is believed that the 
substrate recognition and translocation by a transporter is a multi step process. 
Therefore, determination of interaction sites between the sugar and the protein is an 
important step in elucidating the structural factors that determine specificity in the 
sugar-binding site and allow studies on characterization of the translocation pathway.  
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1.2. Transport Inhibitors of Sodium-D-Glucose Cotransporter 
SGLT1 
Inhibition of glucose uptake in the small intestine is a helpful way for reducing the 
blood glucose level in diabetic patients. SGLT1 has been identified as a potential 
target in the treatment of diabetes, and inhibitors of the transporter are therefore of 
renewed interest (Hirayama et al., 2001; Diedrich, 1966). The cotransport system is 
inhibited by glucosides with either aromatic or aliphatic aglucone residues. Phlorizin, 
a β-glucoside of the aromatic compound phloretin (Figure 1.2), is the most potent 
competitive inhibitor, with an apparent Ki value of 1 µM (Oulianova and Berteloot, 
1996; Hirayama et al., 2001). Phloretin, the aglucone of phlorizin (Figure 1.2), is 
produced by hydrolysis of phlorizin (Hunter, 1993) by removing the glucose moiety 
of phlorizin. Phloretin has a strong inhibitory effect on sugar uptake by SGLT1 
(Panayotova et al., 1997). Both agents are found in apple tree foliage. The 
conformation of phlorizin exhibits an extended coplanar arrangement of the two 
aromatic rings A and B (Figure 1.2). Phlorizin consists of a pyranoside ring and two 
aromatic rings joined by an alkyl spacer. According to the studies performed by 
Wielert Badt et al., 2000, hydrogen bonds from the 2-, 3-, 4-, and 6-OH groups of the 
pyranoside ring and from the 4′- and 6′-OH groups of the aromatic ring A, and 
hydrophobic elements in the same two structures are involved in phlorizin binding to 
SGLT1.  
 
HO
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B
O
HO
HO
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HO
OH
OH
O
A
B
 
I                                                                                  II 
 
FIG. 1.2. Chemical structure of Phlorizin and phloretin. I: Phlorizin, The molecule 
is subdivided into three segments: pyranoside ring, aromatic ring A, and aromatic ring B. II: 
Chemical structure of an aglucone of phlorizin, phloretin [3-(4-hydroxyphenyl)-1-(2,4,6-
trihydroxyphenyl)-1-propanone]. 
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It is proposed that phlorizin binding to SGLT1 is a two-step process: rapid formation 
of an initial collision complex followed by a slow isomerization process that occludes 
phlorizin within its receptor site (Oulianova et al., 2001). Phlorizin is thereby 
supposed to bind to both the sugar binding site and the aglucone binding site, the 
latter with a hydrophobic/aromatic surface (Oulianova and Berteloot, 1996; Hirayama 
et al., 2001). Site-directed mutagenesis studies suggest that a hydrophobic region, 
located in the c-terminus of SGLT1 (amino acids 604-610), is critically involved in 
the binding of phlorizin (Novakova et al., 2001). 
Beside phlorizin, which exhibits an aglucone moiety of a rather complicated structure, 
alkyl glucosides, also, have been demonstrated to inhibit sodium-D-glucose 
cotransport in rabbit, elasmobranch, rat and human brush border membrane vesicles 
(Kipp et al., 1996 and 1997). Alkyl glucosides differ in size depending upon the alkyl 
side chain length. Increase in length of the side chain from 6 to 9 carbon atoms leads 
to a maximum inhibition, whereas very short and very long side chains cause only 
moderate inhibition of SGLT1. Moreover, in skate and shark BBMV, n-alkyl-β-D-
glucosides are significantly more effective inhibitors than the corresponding α-
anomers (Kipp et al., 1997).  
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O
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n-octyl-α-D-glucoside  
 
FIG 1.3. Chemical structures of alkyl glucosides and unsaturated n-hexenyl 
analogs used in this study.  
 
 
In addition, a flexible side chain is required for maximal inhibition as the unsaturated 
compound cis-n-hexenyl-β-glucoside is a significantly more effective inhibitor than 
the corresponding trans-isomer (Figure 1.3). This indicates that for an optimum 
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simultaneous interaction with the D-glucose binding site and hydrophobic domains of 
the transporter, n-alkyl-β-D-glucoside has to exhibit a coiled conformation (Kipp et 
al., 1996).  
 
1.3. Topology of Sodium-D-Glucose Cotransporter SGLT1 
The intestinal Na+/glucose cotransporter SGLT1 was expression-cloned in 1987, and 
found to be the first member of a new gene family. Information on the orientation of 
SGLT1 within the membrane can provide essential clues in understanding the 
structure/function relationship of this important cotransporter protein. To establish a 
topology for a membrane protein, strategies combining computer calculation, 
modeling and experimental tests are usually employed. The initial steps include use of 
the hydropathy analysis (Kyte and Doolittle, 1982), the multiple sequence alignment 
algorithm (Vingron and Agros, 1988), and the approximation of the loop’s orientation 
using the positive-inside rule of von Heijne (1992). A secondary structure model of 
SGLT1 proposed by Turk et al., 1996, is shown in Figure 1.4. The protein consists of 
662-665 amino acid residues with 14 putative transmembrane domains joined through 
several extracellular or intracellular loops (Turk and Wright, 1997). Experimental and 
computational analyses indicate that all transmembrane spans are presumably alpha-
helical (Engelman and Steitz, 1981; Jacobs and White, 1989). An important 
contribution for clarification of the structure and function relationship of the 
transporter would be if topology of the extramembranous loops that flank the 
membrane spans could be clearly assigned.  
The topology of SGLT1 within the membrane is still a matter of argument. The 
localization of the loop residues, particularly the large loop close to the C-terminal 
end (amino acid residues 541-638) which links the transmembrane helices 13 and 14 
(in short, loop 13) has been placed either facing the cytosol or the extracellular space 
as examined by several authors using different experimental approaches (Table 1.1).  
 
Table 1.1. Comparison of Topology of Loop 13 Using Different Prediction Methods 
 
Amino acid 
residues 
His-tag or wild type 
(Lin et al., 1999) 
Exon correlation 
(Turk et al., 1994) 
Glycosylation scan 
(Turk et al., 1996) 
584-589 Extracellular Extracellular Intracellular 
606-630 Extracellular Extracellular Intracellular 
622-627 Extracellular Extracellular Intracellular 
662 + Intracellular Intracellular Extracellular 
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Figure 1.4. A secondary structure model of SGLT1 provided by Turk et al. (1996). 
The topology reveals 14 transmembrane regions, 13 intracellular and extracellular loops. In 
this model, the location of loop 13 was shown as intracellular. 
 
The determination of topology by an appropriate method is still required to assign 
which parts of the transporter form intracellular and extracellular regions in order to 
understand the role of various parts of the transporter during translocation and 
inhibitor complex formation. 
 
1.4. Use of Domains to Study the Structure-Function Relationship 
 
Eukaryotic membrane proteins are particularly difficult to work with. The expression 
of small peptides as functional domains of the transporters can be favoured by using 
suitable hosts. Domains are known as the regions along a single polypeptide chain 
that can act as independent units. To that extent, they can be excised from the chain, 
and still be shown to fold correctly, and often still exhibit biological activity (Sierra et 
al., 2000; Kachalsky et al., 1995). The regions between domains will also tend to be 
fairly simple at a sequence level, often being rich in one or two specific amino acids. 
This would be particularly useful for membrane proteins in which the function of the 
cytoplasmic or extracellular domain is not clear (Lockwood et al., 2003; Selinksky, 
2003). Since loop 13 is involved in interaction of an inhibitor, phlorizin, the in vitro 
expression of this domain can provide direct information of the role of various parts 
Extracellular
Intracellular Loop 13 
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of the peptide during substrate coupling and inhibitor complex formation when the 
whole transporter is not available. 
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2. THE AIMS  
Over the last 30 years, studies using intact membrane vesicles have greatly 
contributed to the characterization of Na+-dependent D-glucose cotransport (SGLT) in 
terms of substrate and inhibitor specificities. In order to examine the involvement of 
different parts of the transporter in interaction with various substrates and inhibitors, it 
is of great interest to understand the mechanism of sequence specific interaction.  
 Our previous site-directed mutagenesis experiments on the glucose transporter 
performed in intact vesicles on a full length protein indicated that C-terminal loop 13 
is involved in phlorizin binding (Novakova et al., 2001). The aim of the present study 
was to confirm this part of SGLT1 as a phlorizin binding domain and to understand 
the mechanism of interaction in more detail. We sought to work on this approach by 
over-expressing mutant loop 13 as a functional domain in vitro that carried single 
tryptophans at different positions as reporter molecules. We wanted to know whether 
the affinity of phlorizin as a potent inhibitor of SGLT1 in the intact carrier is 
comparable to the affinity in an isolated system, to determine the sites of interaction in 
the putative binding pocket, and follow the conformational changes occurring in 
different regions of the peptide when phlorizin interacts with loop 13. As another goal 
of the study, we wanted to forward the same experimental approach to determine 
whether loop 13 also interacts with another type of glucose cotransport inhibitors, 
called alkyl glucosides (Kipp et al., 1996) and whether we can observe the 
conformational changes in the peptide to compare the differences between the mode 
of interaction of phlorizin and/or alkyl glucoside with loop 13.  
 Another purpose of the study was to determine the topology of loop 13 in the 
membrane which is still under a dim light. The previous approaches applied to 
determine the topology could not assign the exact orientation of this part of the 
SGLT1 either inside or outside the membrane. In the forefront to this aim, the point of 
interest was to determine the small sequences of the peptide which can interact with 
the membrane and induce conformational changes upon such interactions. To 
establish a well-defined reconstitution system of loop 13 and lipid vesicles, the 
knowledge of different composition of lipids was required to understand the mode of 
lipid-peptide interaction. Furthermore, the reconstitution studies were aimed to get 
information about the depth of penetration of loop 13 into the lipid membrane.  
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3. EXPERIMENTAL PROCEDURES 
 
3.1. Materials 
Taq DNA polymerase, T4 DNA ligase, restriction enzymes, pCR 2.1-TOPO cloning 
vector, and dNTP’s were obtained from Promega (Mannheim, Germany), New 
England Biolabs (Schwalbach, Germany) or Invitrogen (Karlsruhe, Germany). 
Oligonucleotides were synthesized by MWG Biotech (Ebersberg, Germany). pGEX-
4T-1 vector and BL21 (DE3) cells were from Novagen (Madison, WI) respectively. 
Lysozyme, and protease inhibitor cocktail were purchased from Sigma (Taufkirchen, 
Germany) or Roche Biochemicals (Mannheim, Germany). Thrombin was purchased 
from Sigma. Dioleoylphosphatidylcholine (DOPC), synthetic 1-Palmitoyl-2-stearoyl 
(n-doxyl)-sn-glycero-3-phosphocholine (doxyl PC), with the spin labels at the 5- and 
12-positions of the sn-2-acyl chain, and dioleoylphosphatidylglycerol (DOPG) were 
purchased from Avanti Polar Lipids Inc. The following chemical reagents were from 
Gerbu Biotechnik (Gailberg, Germany), Sigma or Roth (Karlsruhe, Germany) 
available in the highest purity: EDTA, Tris-base, glycine, NaCl, L-Trp, phlorizin, 
phloretin, n-hexyl-β-D-glucoside, trans-n-3-hexenyl-β-D-glucoside, cis-n-3-hexenyl-
β-D-glucoside, n-octyl-β-D-glucoside, n-decyl-β-D-glucoside, 1-hexanol, isopropyl-β-
D-thiogalactopyranoside, 2,5-dihydroxybenzoic acid (DHB) and α-cyano-4-
hydroxycinnamic acid (CHCA).  
 
 
3.2. Molecular Biology 
A coding sequence was amplified by a standard Polymerase Chain Reaction (PCR) 
and the product was purified using the normal primers flanking the mutation site to 
produce an insert with BamHI and EcoRI restriction sites. The resulting 222-base pair 
fragment was isolated from 1.5% agarose gel and ligated in to pCR 2.1-TOPO cloning 
vector and sequenced prior to mutagenesis.  
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3.3. Site-Directed Mutagenesis  
 
Mutagenesis experiments were performed using Chameleon Double Stranded, Site-
directed Mutagenesis Kit (Stratagene, CA) according to the manufacturer’s 
instructions. The following oligonucleotides with mutated nucleotides (underlined) 
were used for mutagenesis. 
Q581W, 5'-GGA GAG GAA GAC ATT TGG GAA GCT CCA GAG GAG-3'  
E591W, 5'-GAG GCC ACT GAC ACA TGG GTT CCT AAG AAG AAG-3' 
R601W, 5’-AAG AAA GGA TTC TTC TGG CGG GCC TAT GAC CTG-3' 
D611W, 5'-CTG TTT TGT GGG CTG TGG CAG GAT AAG GGA CCC-3' 
E621W, 5'-CCC AAG ATG ACC AAG TGG GAG GAG GCT GCC ATG-3' 
L630W, 5'-GCC ATG AAG CTG AAG TGG ACA GAC ACC TCC GAG-3' 
The ApaI site (underlined) was silently introduced in a selection primer as an aid in 
screening with the oligonucleotide primer:  
5'-GCA AAT CGC GCT GTT AGC GGG ACC ATT AAG TTC TGT CTC GGC-3’.  
The mutant cDNAs were sequenced to verify desired mutations at various points. The 
confirmed cDNA’s were ligated into pGEX-4T-1 expression vector. The recombinant 
plasmids were then transformed into BL21 (DE3) cells for expression of wild type 
and Trp mutants of loop 13.  
 
 
3.4. Peptide Expression and Purification 
Amino terminal GST tag peptides of wild type and all mutants were expressed in 
Escherichia coli cells in Lauria-Bertani (LB) medium supplemented with 100 µg/ml 
ampicillin as an antibiotic. Expression of the peptides was induced by addition of 1 
mM isopropyl-β-D-thiogalactopyranoside for 3.5 h at 37 °C in a 2 L culture. Cells 
were pelleted by centrifugation at 8 000 rpm for 10 min at 4 °C; resuspended in 20 
mL of PBS lysis buffer [140 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4 and 1.8 mM 
KH2PO4 (adjusted to pH 7.4)] supplemented with 5 mM DTT, 0.1% Triton X-100, 1 
mg/ml lysozyme, and Protease Inhibitor Cocktail (one tablet). Cells were effectively 
lysed using a SONOPULS Ultrasonic Homogenisation system under mild conditions. 
The lysate was centrifuged at 17 000 rpm for 45 min at 4 °C. The supernatants 
containing GST tag peptides were applied to glutathione-Sepharose columns 
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(Amersham Biosciences, Freiburg, Germany) after being passed through a 0.2 µM 
filter. Soluble fractions of wild type and Trp mutants of loop 13 (amino acid residues 
564-638) after removal of the protease inhibitor were generated by treating the 
glutathione-Sepharose-immobilized fusion peptide, derived from pGEX-4T-1, with 2 
units/ml of thrombin in PBS for 16 h at 4 °C. The purity of wild type and all mutants 
was assessed by SDS-PAGE using a precasted Bis-Tris 4-12% gel in Tris-glycine 
running buffer and staining with Coomassie Blue. The purity of the peptides was at 
least 90%. All peptide concentrations were determined by the method of Lowry using 
bovine serum albumin as a standard (Lowry et al., 1951). 
 
 
3.5. Circular Dichroism Analysis 
The far-UV CD spectra were recorded between 190 and 250 nm (350 µl sample 
volume) on a Jasco J-715 spectropolarimeter equipped with a temperature-controlled 
incubator at 20 °C using quartz cells of 1 mm optical path length and 10 µM of wild 
type loop 13. The step size was 0.5 nm with a 1.0-nm bandwidth at a scan speed of 50 
nm/min. An average of 10 scans was obtained for blank and peptide spectrum, and the 
data was corrected for buffer contributions. The measurements were performed under 
nitrogen flow. The secondary structure percentages were calculated using the K2d 
computer modeling program. The results were expressed as mean residue ellipticity in 
units of degrees/cm2/dmol. The spectrum was recorded in 10 mM phosphate buffer at 
pH 6.8.  
 
3.6. Photoaffinity Labeling of Loop 13 with (2’-Azi-n-Octyl)-β-D-
Glucoside  
 
Photoaffinity labeling was performed with the photolabile alkyl glucoside analogue, 
(2’-Azi-n-octyl)-β-D-glucoside, as previously reported (Gibbs et al., 1982; Lin et al., 
1982). The photolabeling experiments were carried out in 100 µl PBS buffer (pH 7.4) 
containing 225 µg wild type loop 13 peptide and 1 mM (2’-Azi-n-octyl)-β-D-
glucoside. The mixture was preincubated at room temperature in the dark for 5 min. 
After incubation, photolysis was carried out in a Rayonet photochemical reactor RPR-
100 (Southern New England Ultraviolet Co., Branford, CT,) fitted with sixteen, 2800-
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Å lamps at 22 °C for 10 min. As a control, the photoprobe was first exposed to UV 
light and then added to the peptide. No labeling was observed in the absence of UV 
light. After photoaffinity labeling the peptide was precipitated with chloroform 
methanol (v/v 2:1). A small part of the peptide pellet was solubilized with 0.1% 
trifluoroacetic acid in 50% acetonitrile for MALDI-TOF mass spectrometry analysis 
and the rest of the peptide pellet was dissolved in sample buffer for SDS-PAGE. The 
peptide was separated by SDS-PAGE using NuPAGE 4-12% BisTris Gels 
(Invitrogen). Gel was stained with Coomassie Brilliant Blue G-250 (Neuhoff et al., 
1985). Bands of interest were excised from a gel with a clean razorblade, sliced into 
1-mm3 cubes, incubated over night at room temperature with 200 µl of 50 mM 
NH4HCO3, pH 8.5, 50% acetonitrile, dehydrated with 200 µl acetonitrile, and dried in 
a centrifugal evaporator. Gel pieces were rehydrated with a small volume of digestion 
solution (50 mM NH4HCO3, 5 mM CaCl2, and 12.5 ng/µl of trypsin) at 4 °C for 30 
min. Trypsin was used at an enzyme/substrate ratio of ~ 1:100 by weight. Digestion 
was allowed to proceed overnight at 37 °C. Peptides were extracted from the gel 
pieces with 100 µl of 20 mM ammonium bicarbonate, followed by 2 extractions of 
1:1 water/acetonitrile plus 1% trifluoroacetic acid and one extraction with 100 µl of 
acetonitrile. Each extraction step was carried out after incubation of samples for 10 
min at room temperature. All extracts were combined in a fresh tube, flash-frozen, 
and dried in a centrifugal evaporator. Dried extracts were stored at -20° C until 
analyzed. Mass spectra were acquired in the positive ion, linear mode on a Voyager 
DE-PRO MALDI (PE-Biosystems, Shelton, CA). After mixing the solubilized peptide 
with 2,5-dihydroxybenzoic acid matrix (saturated 2,5-dihydroxybenzoic acid solution 
in 0.1% trifluoroacetic acid in 50% acetonitrile) for intact loop 13 peptide, and for 
acquisition of a mass spectrometric peptide map of the trypsin digested peptide, 0.5-µl 
aliquots of the generated cleavage products were dispensed onto the sample support, 
followed by 0.5 µl of α-cyano-4-hydroxycinnamic acid matrix solution (solution of α-
cyano-4-hydroxycinnamic acid in 0.1% trifluoroacetic acid in 50% acetonitrile).  
Samples were deposited on a MALDI plate and dried at room temperature prior to 
collecting the spectra. 
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3.7. Preparation of Lipid Vesicles 
Chloroform solutions of DOPC and DOPG (10 mg/ml stock solution) were mixed to 
obtain 70:30 and 60:40 percent molar ratios of zwitterionic and negatively charged 
lipids, respectively. The lipid mixtures were dried under a gentle stream of nitrogen 
for 3 h. To the dried phospholipid film, PBS (pH 7.4) was added at 35 °C to a final 
concentration of 2 mg/ml and the glass tube was covered with parafilm. After 1 hr, the 
phospholipids were vigorously shaken. Small unilamellar vesicles (SUVs) were 
prepared by sonication in a bath sonicator, applying cycles of 5 min pulse at 3 min 
interval for ~2 h above the transition temperature (Tc) of the lipids to get a nearly 
clear solution. A homogenous liposome size distribution of ~75 nm was confirmed by 
dynamic light scattering analysis, using a Dynamic Light Scattering ISS720 device. 
SUVs were freshly prepared for all reconstitution studies. 
 
3.8. Preparation of Peptide-Lipid Vesicles 
The peptide-lipid complexes were prepared in clean small glass test tubes in 500 µl 
volume. After mixing 3 µM of each mutant with lipid vesicles (150 µM), the reaction 
mixture was further sonicated applying 2-3 cycles of 3 min pulse at 2 min interval. 
The reaction mixture was incubated at room temperature for 10 min. All samples were 
then transferred to 0.3 cm quartz cell to collect the emission spectra. 
 
3.9. Steady State Trp Fluorescence  
The fluorescence experiments were performed using a Perkin-Elmer LS 50B 
fluorescence spectrometer (Perkin-Elmer), fitted with a 450W xenon arc lamp at room 
temperature. A 0.3-cm excitation and emission path length quartz cell was used for all 
the fluorescence measurements. The excitation wavelength was set at 295 nm for 
selective excitation of Trp. A 290 nm cutoff filter was used to minimize the 
contribution of scattering signals. Emission spectra were collected from 300-400 nm, 
averaging six scans. The bandwidths for both excitation and emission 
monochromators were 5 nm. The emission spectra were corrected for background and 
dilution effects. 
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3.10. Ligand Binding Assay 
3.10.1. Binding of Phlorizin/Phloretin to Single Trp Mutants  
 
The ligand-induced fluorescence quenching as a function of phlorizin or phloretin 
concentration was monitored as described (Xia et al., 2003). Increasing amounts of 
phlorizin or phloretin (from 1 to 650 µM) were added to all Trp mutants (5 µM) in 
PBS. Briefly, as increasing amounts of phlorizin or phloretin were added, the 
fluorescence intensity decreased. Apparent binding constants were calculated from 
titration data by determining the percentage of quenching at saturating phlorizin or 
phloretin concentrations using single-site binding equation in a non-linear regression 
analysis program, Prism (Graphpad, San Diego, CA).  
 
3.10.2. Binding of n-Hexyl-β-D-Glucoside to Single Trp Mutants  
 
Fluorescence quenching was observed in the presence of various concentrations of n-
hexyl-β-D-glucoside for each mutant. This signal was utilized to calculate the 
dissociation constants. Increasing amounts of n-hexyl-β-D-glucoside (from 1 to 350 
µM) were added to all mutants (5 µM) in PBS (pH 7.4). The corrected relative 
fluorescence intensity at different ligand concentrations was determined. Apparent 
binding constants were calculated using a single-site binding equation in the non-
linear regression analysis program, Prism (Graphpad, San Diego, CA).  
 
 
3.11. Fluorescence Quenching by Acrylamide  
3.11.1. Effect of Phlorizin/Phloretin on Acrylamide Quenching of Trp Mutants  
 
Acrylamide-dependent Trp fluorescence quenching experiments were performed in 
PBS (pH 7.4) for wild type and mutant peptides (5 µM) in the absence and presence 
of 50 µM phlorizin or phloretin. Acrylamide was added from aliquots of an 8 M stock 
solution to each peptide solution (25 °C) up to 500 mM. The peptides were incubated 
with the substrate at room temperature for 2 min prior to collecting the fluorescence 
spectra. The accessibility of Trp was monitored by analysing the quenching data using 
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a Stern-Volmer equation: F0/F = 1 + KSV  [Q] (Lackowicz, 1999), where F0 is the 
fluorescence of the peptide in the absence of quencher and F is the observed 
fluorescence at the concentration of the quencher ([Q]). KSV is the collisional 
quenching constant which was determined from the slope of best fit values of Stern-
Volmer plots at a given concentration of the quencher. The difference between inner 
filter effects of substrate (50 µM) from the titration of L-Trp (5 µM) performed at an 
excitation of 295 nm and emission at 355 nm was found to be much less and hence 
was not considered in our measurements.  
 
3.11.2. Effect of Various Alkyl Glucosides on Acrylamide Quenching of Trp 
Mutants  
 
Trp fluorescence quenching experiments were performed in PBS (pH 7.4) for all Trp 
mutants (5 µM) in the absence and presence of 30 µM of n-hexyl-β-D-glucoside, 
trans-n-3-hexenyl-β-D-glucoside, cis-n-3-hexenyl-β-D-glucoside, n-octyl-β-D-
glucoside, n-decyl-β-D-glucoside or 1-hexanol. Acrylamide was added at room 
temperature as aliquots from a 5 M stock solution to each mutant peptide solution up 
to 350 mM. The accessibility of each Trp was monitored by analysing the quenching 
data using a Stern-Volmer equation as described in section 3.11.1. The difference 
between inner filter effects of the ligands found for the titration of a L-Trp solution (5 
µM) at an excitation of 295 nm and emission at 355 nm was found to be much less 
and hence was not considered further in our measurements.  
 
3.11.3. Effect of Lipid Vesicles on Acrylamide Quenching of Trp Mutants  
 
Acrylamide quenching experiments were carried out at an excitation wavelength of 
295 nm to reduce the absorbance by acrylamide. Small aliquots of acrylamide were 
added from 5 M stock solution up to 350 mM to 3 µM of each Trp mutant in the 
absence and presence of pure PC and PC/PG (60:40 and 70:30 % molar ratios, 
respectively) vesicles at 150 µM lipid concentration. All measurements were 
performed in PBS (pH 7.4). The data were analysed according to the Stern-Volmer 
equation as described in section 3.11.1. 
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4. RESULTS 
 
4.1. Expression and Purification of Wild Type and Mutant Peptides  
 
Peptides were expressed in Escherichia coli and purified with a yield of ~2.5mg/L 
culture. Plasmid pGEX-4T-1 containing wild type loop 13 generates a Trp-free 
peptide, thus the introduced Trp is the only reporter group for each of the mutant 
peptides. To determine whether the correct product was expressed, MALDI-mass 
spectrometry was performed which shows the mass peak at m/z 8689.56 as expected 
for loop 13 on the basis of the amino acid sequence (Figure 4.1A). The purity of all 
single Trp mutants was assessed by SDS-PAGE (Figure 4.1B). 
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FIG. 4.1. Purification of Wild type and single Trp mutants of loop 13 (564-638 
amino acid residues). A, MALDI-mass spectrometry of loop 13. B, Coomassie Blue-stained 
polyacrylamide gel of the GST cleaved peptides (10 µg/lane). Lane 1; Protein standard (kDa), 
Lane 2-7; six single Trp mutants (~9 kDa) after trypsin digestion of GST fusion protein.  
28 
14 
38 
B 
  Results 
 
   
  17
 
  
 
4.2. Secondary Structure of Loop 13 as Determined by CD Analysis 
 
The Circular Dichroism (CD) spectrum of loop 13 at pH 6.8 is shown in Figure 4.2. 
The CD spectrum shows characteristic minima at 222 and 208 nm from which the 
secondary structure was estimated to consist of 37% α-helical residues and 63% 
random coil.  
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FIG. 4.2. Secondary structure of loop 13 as revealed by CD spectroscopy. CD 
spectrum was recorded as described under “Experimental Procedures.” The measurement was 
carried out at 10 µM peptide concentration in 10 mM phosphate buffer (pH 6.8) at 20 °C. 
 
 
4.3. Computer Modeling of Loop 13  
 
To predict the secondary structure of loop 13 determined by CD analysis, the 
computer-modeling program PSIPRED (McGuffin et al., 2000) was used which is 
shown in Figure 4.3 as a graphical output prediction. The program predicts about 40% 
α-helical residues and 60% random coil, while no beta strands were detected in the 
peptide. The 75 amino acids of loop 13 are shown in the form of amino acid codes.  
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FIG. 4.3. Primary sequence analysis of loop 13 by computer-modeling program 
PSIPRED. The predicted α-helices are shown in green. Black lines represent the random coil 
of loop 13. The sequence of loop 13 is shown from amino acid residues 564 to 638. The 
positions of six single-Trp residues are shown in red.  
 
 
4.4. Positions of Six Single Trp-Mutations on Loop 13 
 
Site-specific mutations were performed to introduce single Trp residues at six 
different positions of the molecule which are shown in Figure 4.3. The single 
mutations at the six positions of the molecule did not affect the structure of loop 13 
significantly as determined by computer modeling primary sequence analysis of all 
Trp mutants (not shown). The derived model was further exploited to determine the 
sequence specific interaction between inhibitor and Trp mutants of loop 13 by 
fluorescence measurements (see section 4.5). 
 
 
4.5. Interaction of Phlorizin with Loop 13  
 
4.5.1. Effect of Phlorizin on Trp Fluorescence  
4.5.1.1. Mutants Q581W and E591W: Fluorescence and Effect of Phlorizin 
 
The corrected spectra of Trp fluorescence (λex = 295 nm) of Q581W and E591W are 
shown in Figure 4.5.1 (black lines). The emission maxima of both Trp mutants are in 
the range of 348–350 nm, which is typical for a hydrophilic environment. 100 µM 
phlorizin was used to monitor the percentage of quenching regarding the various 
positions of each Trp mutant. The effects of phlorizin on these mutants are compiled 
in Figure 4.5.1 (red lines) and Table 4.5.1.  
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4.5.1.2. Mutants R601W, D611W, E621W and L630W: Fluorescence and 
Effect of Phlorizin 
 
The corrected Trp fluorescence spectra of R601W, D611W, E621W, and L630W are 
shown in Figure 4.5.1 (black lines). The fluorescence maxima for these proteins are in 
the range of 341–343 nm, indicating a slightly less polar environment compared with 
Q581W and E591W. The effects of phlorizin on these mutants are compiled in Figure 
4.5.1 (red lines) and Table 4.5.1.  
The differences between the fluorescence quenching spectra of the various 
mutants suggest that different segments of loop 13 react differently to the binding of 
phlorizin to the loop. Such differences could, however, also be due to differences in 
the phlorizin affinity of the mutants. We therefore determined the apparent binding 
affinities (section 4.5.2).  
 
 
 
 
 
 
 
 
 
Table 4.5.1. Comparison of the Effect of Phlorizin on Trp Fluorescence of Each 
Single Trp Mutant (as shown above). 
 
Fluorescence Intensity (%) Fluorescence maxima (nm) Peptide 
No a phlorizin ∆ (quenching) No phlorizin ∆ (shift)
Q581W 100 46 54 348 351 +3 
E591W 100 42 58 349 355 +6 
R601W 100 33 67 342 350 +8 
D611W 100 20 80 341 355 +14 
E621W 100 35 65 343 354 +11 
L630W 100 82 18 343 353 +10 
a The values are the percentage of fluorescence yield in the absence of phlorizin 
∆ Delta represents the differences between the values 
+ Represents a red shift in maxima 
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FIG. 4.5.1. Effect of phlorizin on fluorescence emission spectra of single Trp mutant 
peptides. The black lines show the corrected spectra and the red lines represent the effect of 
100 µM phlorizin on the intrinsic fluorescence of each Trp mutant. All the spectra were 
corrected as described under “Experimental Procedures.” The percentages of fluorescence 
quenching for each Trp mutant are presented in the section “Results” and derived from three 
independent experiments.  
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4.5.2. Phlorizin Binding to the Trp Mutants 
 
Titration of all single Trp mutants of loop 13 with different concentrations of 
phlorizin is shown in Figure 4.5.2. About 90% of the fluorescence of each mutant was 
quenched at the highest concentration of phlorizin. The estimated equilibrium 
dissociation constants (Kd) for all mutants are presented in Table 4.5.2. For calculation 
of binding constants, the peak points with shifting toward longer wavelength were 
collected for each addition of phlorizin.  
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FIG. 4.5.2. Titration of single Trp mutants of loop 13 with phlorizin. All experiments 
were conducted as described under “Experimental Procedures.” Samples include Q581W 
(), E591W ( ), R601W (▲), D611W (▼), E621W (), and L630W (◄). The percentage of 
quenching at saturating phlorizin concentration was calculated from the data and the values 
were fitted to a single site binding equation using Prism (Graphpad, San Diego, CA) to 
calculate equilibrium dissociation constants. The Kd values for all mutants are summarized in 
Table 4.5.2.  
 
The mutant peptides (e.g. Q581W, E591W, R601W, E621W and L630W) showed 
values very similar to the wild type loop 13 (Xia et al., 2003) indicating that the 
replacement of amino acids at these positions by Trp residues does not change the 
ability of the peptide to bind phlorizin. There is, however, a lower affinity of mutant 
peptide D611W which is consistent with the mutagenesis studies on the whole 
protein. 
  Results 
 
   
  22
 
  
 
 
Table 4.5.2. Apparent Affinity of Phlorizin to the Single Trp Mutants of Loop 13 
 
Parameters of phlorizin binding were derived from the data shown in Figure 4.5.2. 
 
Peptide Kd  
(µM) 
Q581W 18 ± 2 
E591W 25 ±11 
R601W 15 ± 7 
D611W 54 ± 12 
E621W 26 ± 8 
L630W 19 ± 5 
Values are the mean ± standard deviation of two or three independent experiments. 
 
 
 
4.5.3. Effect of Phlorizin on Trp Accessibility to Collisional Quenching 
 
The collisional quencher acrylamide was used to detect changes in the ‘accessibility’ 
of Trp to the surrounding solvent. The Stern-Volmer quenching plots of each mutant 
in which F0/F is plotted against the acrylamide concentration in the presence and 
absence of phlorizin were linear and are shown in Figure 4.5.3. The Stern-Volmer 
constants for all mutants are compiled in Table 4.5.3. At 50 µM phlorizin, a non 
significant protection effect was noted for mutant Q581W. For E591W and R601W 
mutant peptides the Stern-Volmer constants started to increase and about four to five 
fold increase by phlorizin was found for D611W. E621W showed less change in 
quenching and almost no change in quenching was observed for mutant L630W. 
These data suggest that the major conformational changes are initiated by phlorizin at 
and/ or in the vicinity of amino acid 611. Furthermore, the accessibility to acrylamide 
is increased in between the region 591 to 621 by phlorizin suggesting an unfolding of 
the peptide in this region. 
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FIG. 4.5.3. Stern-Volmer plots of Trp fluorescence quenching by acrylamide. 
Quenching experiments were conducted as described under “Experimental Procedures.” In 
each panel the samples were investigated in the absence () and presence ( ) of 50 µM 
phlorizin. The slopes of the best fit lines for each data set (KSV values) are shown in Table 
4.5.2. Mean values ± standard deviation of two or three independent experiments are given. 
As a control, 50 µM phlorizin had no effect on acrylamide quenching of L-Trp (5 µM) 
solution.  
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Table 4.5.3. Stern-Volmer Constants of Single-Trp Mutants of Loop 13 
 
Fluorescence parameters were determined from the data shown in Figure 4.5.3. 
 
a Quenching experiments were conducted in the absence (-) or presence (+) of 50 µM 
phlorizin. 
b The Stern-Volmer quenching constants were determined from the slopes of the lines of 
F0/F = 1 + KSV [Q]. Values are the mean ± standard deviation of two or three independent 
experiments. 
 
 
4.5.4. Effect of Phloretin and Glucose on Trp Fluorescence and Accessibility to 
Collisional Quenching 
To investigate which part of the glucoside, the sugar or the aglucone, elicited the 
conformational changes in the peptides, the effect of phloretin, the aglucone of 
phlorizin, and D-glucose on Trp quenching and accessibility was tested. Experiments 
were also performed in the presence of phloretin and/or D-glucose for D611W. The 
corrected spectra of Trp fluorescence (λexc = 295 nm) of D611W, in the absence and 
presence of 100 µM phloretin and D-glucose, are shown in Figure 4.5.4 A and C, 
respectively. The fluorescence of D611W was quenched upon addition of phloretin by 
69% with a 9-10 nm red-shift in spectrum. No quenching was observed in the 
presence of D-glucose. The linear Stern-Volmer quenching plot of D611W in the 
absence and presence of phloretin is shown in Figure 4.5.4 B. An increase in Stern-
Volmer quenching constant for D611W from 11 to 31 M-1 was observed. In the 
presence of 50 µM D-glucose, no significant effect was observed (Figure 4.5.4 D). 
 
Peptide Phlorizin a KSV (M-1) b 
Q581W - 
+ 
11 ± 3 
9 ± 2 
E591W - 
+ 
25 ± 4 
38 ± 5 
R601W - 
+ 
20 ± 5 
39 ± 4 
D611W - 
+ 
11 ± 2 
55 ± 8 
E621W - 
+ 
17 ± 3 
29 ± 6 
L630W - 
+ 
10 ± 3 
11 ± 4 
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FIG. 4.5.4. Effect of phloretin and D-glucose on fluorescence emission spectrum of 
D611W. A, The black line shows the corrected spectrum and the red line represents the effect 
of 100 µM phloretin. B, Stern-Volmer plots of Trp fluorescence quenching of D611W by 
acrylamide in the absence () and presence ( ) of 50 µM phloretin. C, The black line 
shows the corrected spectrum and the red line represents the effect of 100 µM D-glucose on 
Trp fluorescence. D, Stern-Volmer plots of Trp fluorescence quenching of D611W by 
acrylamide in the absence () and presence ( ) of 50 µM D-glucose. The spectra were 
corrected as described under “Experimental Procedures.” Data were derived from two or three 
independent experiments. Quenching experiments were conducted as described under 
“Experimental Procedures.” 
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4.6. Interaction of Alkyl Glucosides with Loop 13 
4.6.1. Photoaffinity Labeling of Loop 13 with (2′-Azi-n-Octyl)-β-D-Glucoside 
 
In contrast to the phlorizin studies, there was no experimental evidence that alkyl 
glucosides interact at all with loop 13. We used a photolabeled compound, (2′-Azi-n-
octyl)-β-D-glucoside, which was available in our group to test for an interaction. The 
photolabeling experiments were performed and analysed by MALDI-mass 
spectrometry. Figure 4.6.1.1.A shows the expected mass peak for loop 13 at m/z 
8689.56 before photolabeling. After photoaffinity labeling, an additional peak of m/z 
9025.28 was observed (Figure 4.6.1.1.B). The mass difference between the first peak 
(loop 13) and the second peak (*) corresponds to the mass of the photolyzed (2′-Azi-
n-octyl)-β-D-glucoside. Another peak close to m/z 7700 was observed which probably 
represents a degradation product of the peptide. Furthermore, to determine the sites of 
interaction, photolabeled loop 13 was digested in-gel with trypsin. After extraction of 
the peptides from the gel, the resulting mixture was analysed by MALDI-TOF. The 
only additional peak observed in the labeled probe was at m/z 845.05 (Figure 4.6.1.2 
A and B). This corresponds to an adduct of the peptide Gly-Phe-Phe-Arg of m/z 
526.27 (amino acid residues 598-601) with the photolyzed (2′-Azi-n-octyl)-β-D-
glucoside (m/z 318.78).  
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FIG. 4.6.1.1. MALDI-mass spectrometry of photoaffinity-labeled loop 13. Peptide was 
incubated with (2′-Azi-n-octyl)-β-D-glucoside in PBS for 5 min in the dark at room 
temperature, followed by irradiation at 280 nm for 5 min. After separation from 
noncovalently bound (2′-Azi-n-octyl)-β-D-glucoside by chloroform/methanol extraction, 
peptide was dissolved in 2,5-dihydroxybenzoic acid matrix. (A) Loop 13 (m/z 8689.56) before 
photoaffinity labeling, (B) Loop 13 after photoaffinity labeling. The asterisk denotes loop 13 
cross-linked with photolyzed (2′-Azi-n-octyl)-β-D-glucoside (m/z 9025.28). a.u., arbitrary 
units.  
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FIG. 4.6.1.2. MALDI mass spectrometry of photoaffinity-labeled loop 13 after in-gel 
trypsin digestion. The loop 13 was photolabeled with (2′-Azi-n-octyl)-β-D-glucoside, 
peptides were separated by SDS-PAGE and peptide bands of interest were excised, destained 
and digested in gel with trypsin. The peptides were extracted as described under 
‘Experimental Procedures’, and MALDI mass spectra were recorded: (A) Loop 13 before 
photoaffinity labeling, (B) Loop 13 after photoaffinity labeling with (2′-Azi-n-octyl)-β-D-
glucoside. The asterisk denotes the additional peak at m/z 845.05 which is an adduct of m/z 
526.27 due to modification of the Gly-Phe-Phe-Arg peptide (amino acid residues 598-601) 
with photolyzed (2′-Azi-n-octyl)-β-D-glucoside (m/z 318.78). 
 
 
 
4.6.2. Effect of n-Hexyl-β-D-Glucoside on Trp Fluorescence  
We then tested whether n-hexyl-β-D-glucoside changed the steady state fluorescence 
of loop 13 mutants. The corrected Trp fluorescence spectra of Q581W, E591W, 
R601W, D611W, E621W and L630W in the absence and presence of n-hexyl-β-D-
glucoside are shown in Figure 4.6.2 and compiled in Table Fluorescence quenching 
and shifts in the maximum were observed for each mutant, although to a different 
extent.  
 
  Results 
 
   
  28
 
  
 
 
320 340 360 380 400
0,0
0,1
0,2
0,3
0,4
0,5
0,6
Fl
uo
re
sc
en
ce
 In
te
ns
ity
 [a
rb
itr
ar
y 
un
its
]
Wavelength (nm)
Q581W
320 340 360 380 400
0,0
0,1
0,2
0,3
0,4
0,5
0,6
320 340 360 380 400
0,0
0,1
0,2
0,3
0,4
0,5
0,6
Fl
uo
re
sc
en
ce
 In
te
ns
ity
 [a
rb
itr
ar
y 
un
its
]
Wavelength (nm)
E591W
320 340 360 380 400
0,0
0,1
0,2
0,3
0,4
0,5
0,6
 
 
 
320 340 360 380 400
0,0
0,1
0,2
0,3
0,4
0,5
0,6
Fl
uo
re
sc
en
ce
 In
te
ns
ity
 [a
rb
itr
ar
y 
un
its
]
Wavelength (nm)
R601W
320 340 360 380 400
0
2
4
6
8
10
 
320 340 360 380 400
0,0
0,1
0,2
0,3
0,4
0,5
0,6
Fl
uo
re
sc
en
ce
 In
te
ns
ity
 [a
rb
itr
ar
y 
un
its
]
Wavelength (nm)
D611W
320 340 360 380 400
0,0
0,1
0,2
0,3
0,4
0,5
0,6
 
 
 
 
320 340 360 380 400
0,0
0,1
0,2
0,3
0,4
0,5
0,6
Fl
uo
re
sc
en
ce
 In
te
ns
ity
 [a
rb
itr
ar
y 
un
its
]
[Wavelength] nm
E621W
320 340 360 380 400
0,0
0,1
0,2
0,3
0,4
0,5
0,6
320 340 360 380 400
0,0
0,1
0,2
0,3
0,4
0,5
0,6
Fl
uo
re
sc
en
ce
 In
te
ns
ity
 [a
rb
itr
ar
y 
un
its
]
Wavelength (nm)
L630W
320 340 360 380 400
0,0
0,1
0,2
0,3
0,4
0,5
0,6
 
 
FIG. 4.6.2. Effect of n-hexyl-β-D-glucoside on fluorescence emission spectra of single 
Trp mutants of loop 13. The black lines show the corrected spectra in the absence of n-
hexyl-β-D-glucoside, the blue lines represent the effect of 100 µM n-hexyl-β-D-glucoside on 
the intrinsic fluorescence.  
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Table 4.6.1. Summary of the Effect of n-Hexyl-β-D-Glucoside on Trp Fluorescence of 
Each Single Trp Mutant (as shown in Figure 4.6.2). 
 
 
Fluorescence Intensity (%) Fluorescence maxima (nm) Peptide 
No a n-hexyl  ∆ (quenching) No n-hexyl ∆ (shift)
Q581W 100 87 13 348 348 zero 
E591W 100 97 3 349 349 zero 
R601W 100 74 26 342 343 -1 
D611W 100 60 40 341 339 -2 
E621W 100 46 54 343 344 +1 
L630W 100 54 46 343 340 -3 
 
a The values are the percentage of fluorescence yield in the absence n-hexyl-β-D-
glucoside  
∆ Delta represents the differences of the values presented in a and b. 
+ Indicates a red shift in maxima 
– Indicates a blue shift in maxima 
 
 
 
The differences between the fluorescence quenching spectra of the various mutants, in 
particular the shifts in the maxima suggest that the various segments of loop 13 react 
differently to the binding of n-hexyl-β-D-glucoside.  
 
4.6.3.  Binding of n-Hexyl-β-D-Glucoside to Single Trp Mutants  
Affinity of the mutants to n-hexyl-β-D-glucoside was determined by titration of the 
Trp mutants with different concentrations of n-hexyl glucoside, as shown in Figure 
4.6.3. Since, we did not observe remarkable changes in Trp fluorescence for Q581W 
and E591W, the binding affinities were not determined. A maximum quenching of 
about 55% of the fluorescence was observed for other mutants (R601W, D611W, 
E621W, and L630W) at high concentrations of n-hexyl-β-D-glucoside. The estimated 
equilibrium dissociation constants for all mutants are presented in Table 4.6.2. They 
are similar for all mutants and range from 8-14 µM, values comparable to the affinity 
of n-hexyl-β-D-glucoside for the intact SGLT1 in natural membranes (Kipp et al., 
1997). 
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FIG. 4.6.3. Titration of single Trp mutants of loop 13 with n-hexyl-β-D-glucoside. All 
experiments were conducted as described under “Experimental Procedures.” Samples include 
R601W (), D611W ( ), E621W (▲) and L630W (▼). The percentage of quenching at 
high n-hexyl-β-D-glucoside concentration was calculated from the data and the values were 
fitted to single site binding equation using Prism (Graphpad, San Diego, CA) to calculate 
equilibrium dissociation constants. The Kd values for all mutants are summarized in Table 
4.6.2. 
 
 
4.6.4. Effect of n-Hexyl-β-D-Glucoside on Trp Accessibility to Collisional 
Quenching 
The water soluble collisional quencher acrylamide was used to measure the changes 
in accessibility of each Trp upon n-hexyl-β-D-glucoside addition. The Stern-Volmer 
quenching plots in which F0/F is plotted against the acrylamide concentration in the 
presence and absence of 30 µM n-hexyl-β-D-glucoside are shown in Figure 4.6.4. All 
plots were linear with a regression coefficient higher than 0.99. The Stern-Volmer 
constants for all mutants are compiled in Table 4.6.2. Maximum decrease in 
accessibility was noted for mutant R601W, slight protection was observed for D611W 
and L630W. In contrast, a slight increase in Trp accessibility was found for E621W.  
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FIG. 4.6.4. Stern-Volmer plots of Trp fluorescence quenching by acrylamide.  
Quenching experiments were conducted as described under “Experimental Procedures.” In 
each panel the samples were investigated in the absence () and presence ( ) of 30 µM n-
hexyl-β-D-glucoside. The slopes of the best fit linear regression lines for each data set (KSV 
values) are shown in Table 4.6.2.  
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Table 4.6.2. Acrylamide Accessibility and Apparent Affinity of n-Hexyl-β-D-
Glucoside to the Single-Trp mutants of Loop 13a 
 
Peptide n-hexyl-β-D-
glucoside b  
KSV c 
(M-1) 
Kd d 
(µM) 
Q581W - 
+ 
11 ± 2 
9 ± 2 
- 
E591W - 
+ 
21 ± 3 
19 ± 4 
- 
R601W - 
+ 
21 ± 3 
8 ± 1 
12 ± 4 
 
D611W - 
+ 
11 ± 2 
8 ± 2 
8 ± 3 
 
E621W - 
+ 
12 ± 3 
16 ± 2 
14 ± 6 
 
L630W 
 
- 
+ 
11 ± 1 
8 ± 1 
9 ± 2 
 
a Parameters of n-hexyl-β-D-glucoside binding and acrylamide accessibility were 
derived from the data shown in Figures 4.6.3 and 4.6.4, respectively.  
b Quenching experiments were conducted in the presence (+) or absence (-) of 30 µM 
n-hexyl-β-D-glucoside. 
c The Stern-Volmer constants were determined from the slopes of the linear regression 
lines from plots of F0/F = 1 + KSV  [Q]. Values are mean ± standard deviation of two 
or three independent experiments. 
d The apparent equilibrium dissociation constants (Kd) are means ± standard deviation 
of two or three independent experiments. 
 
 
 
4.6.5. Stereo-selectivity of the Interaction of Alkyl Glucosides with Loop 13 
In intact brush border membranes, a distinct stereo-selectivity was observed for the 
interaction of alkyl glucosides with SGLT1 (Kipp et al., 1996). The position of the 
residue at C1 (β versus α), the conformation after introducing a double bond at C3-C4 
(cis versus trans) and the chain length (C6-C10) turned out to be of importance. We 
therefore investigated the interaction of the corresponding compounds with loop 13 in 
vitro. Similar to the studies on intact membranes, the β-glucosides exhibited a more 
marked change in fluorescence than the α-glucosides, the same holds true for the 
preference of the cis versus the trans conformation at C3-C4. Extension of the alkyl 
chain beyond C6 and C10, however, reduced the responses (see Table 4.6.3.). 
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4.6.6. Effect of 1-Hexanol on Trp Fluorescence and Accessibility to Collisional 
Quenching 
To investigate which part of the alkyl glucoside, the sugar or the aglucone, is involved 
in the interaction with loop 13, 1-hexanol and D-glucose were used as ligands. The 
fluorescence of R601W was quenched upon addition of 100 µM 1-hexanol by 45% 
with a red shift in maxima by 0.5-1 nm (Figure 4.6.6.A). Also a significant protection 
effect was observed for 1-hexanol (decrease of KSV to 13 M-1 from 21 M-1, Figure 
4.6.6.B). No quenching and protection against acrylamide was observed in the 
presence of glucose as described under Section 4.5.4.  
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FIG. 4.6.6 (A) Effect of 1-hexanol on the fluorescence emission spectrum of R601W. 
The black lines show the corrected spectrum and the blue lines represent the effect of 100 µM 
1-hexanol on intrinsic fluorescence. The spectra were corrected as described under 
“Experimental Procedures.” Data were derived from three independent experiments. (B) 
Stern-Volmer plots of Trp fluorescence quenching of R601W by acrylamide in the absence 
() and presence ( ) of 30 µM 1-hexanol. Quenching experiments were conducted as 
described under “Experimental Procedures.” 
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Table 4.6.3. Effect of Alkyl Glucoside Analogues on Mutant R601Wa 
 
Glucoside  
 
Quenching b 
(%) 
KSV c 
(M-1) 
n-octyl-β-D-glucoside 
 
35 - 
+ 
21 ± 3 
13 ± 3 
n-octyl-a-D-glucoside 
 
3 - 
+ 
21 ± 3 
20 ± 2 
trans-n-3-hexenyl-β-D-
glucoside 
20 
 
- 
+ 
21 ± 3 
14 ± 2 
cis-n-3-hexenyl-β-D-
glucoside 
28 
 
- 
+ 
21 ± 3 
9 ± 2 
n-hexyl-β-D-glucoside 26 - 
+ 
21 ± 3 
8 ± 1 
n-decyl-β-D-glucoside 
 
16  
 
- 
+ 
21 ± 3 
18 ± 2 
a The parameters were derived from the fluorescence quenching data and acrylamide
 accessibility (not shown). 
b Values represent fluorescence quenching in the presence of a concentration of each 
glucoside of 100 µM. 
c Quenching experiments were conducted in the absence (-) or presence (+) of each 
glucoside at a concentration of 30 µM.  
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4.7. Interaction of Loop 13 with Lipid Vesicles 
4.7.1. Effect of Lipid Vesicles on Trp Fluorescence 
 
The corrected Trp fluorescence spectra (λexc = 295 nm) of Q581W, E591W, R601W, 
D611W, E621W and L630W in the absence and presence of 150 µM DOPC:DOPG 
(60:40%) are shown in Figure 4.7.1 and compiled in Table 4.7.1. Increase in 
fluorescence and shifts in the maximum were observed for all mutants, except 
R601W, although to a different extent.  
 
 
 
 
 
Table 4.7.1. Summary of the Effect of Vesicles on Trp Fluorescence of Each Single-
Trp Mutant (as shown in Figure 4.7.1). 
 
Fluorescence 
intensity (%) 
Fluorescence maxima (nm) Peptide 
 (increase) a No PC:PG 
(60:40%) 
∆ (shift) 
Q581W 23 348 342 -6 
E591W 28 349 347 -2 
R601W zero 342 342 zero 
D611W 20 341 340 -1 
E621W 17 343 340 -3 
L630W 60 343 340 -3 
 
a The values are the percentage of increase in fluorescence in the presence of PC:PG 
(60:40%) 
∆ Delta represents the differences between the values 
– Indicates a blue shift in maxima 
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FIG. 4.7.1. Effect of DOPC:DOPG (60:40%) on fluorescence emission spectra of 
single Trp mutants of loop 13. The black lines show the corrected spectra of Trp mutants (3 
µM) in simple buffer (PBS, pH 7.4) and the green lines represent the effect of 150 µM lipid 
vesicles on Trp fluorescence.  
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4.7.2. Fluorescence Quenching by Membrane-Embedded Doxyl Spin Labels 
The liposome-induced blue shifts and increases in fluorescence intensity of Trp 
mutants suggest that upon formation of the peptide-lipid complex, the Trp residues 
Q581W, E621W, and L630W shift to a more hydrophobic environment. This 
relatively hydrophobic environment could lie either within the protein or in the lipid 
bilayer. To discriminate between these possibilities, we examined the ability of lipid-
embedded nitroxide spin labels to quench the fluorescence of each Trp reporter 
groups. Only Trp residues that can interact directly with the nitroxide spin groups 
become quenched. For these experiments, PC:PG (60:40%) vesicles were prepared 
that contained doxyl-PC labeled at either 5-, or 12-position of the sn-2 acyl chain.  
All Trp mutants were mixed with constant amount of vesicles containing 50% 
PC, 10% doxyl-PC, and 40% PG. The spectra from these experiments are shown in 
Figures 4.7.2.1-4.7.2.3, and the degree of quenching by the nitroxide groups is 
tabulated in Table 4.7.2. From these spectra, it is apparent that the doxyl-spin labels 
efficiently quenched Trp at position 621 and 630. Trp fluorescence of E621W is 
strongly quenched by 5-doxyl spin label and 12-doxyl spin label has almost the same 
effect on quenching. This would suggest the deep embedding of Trp-621 in the 
membrane. L630W fluorescence is strongly quenched by 5-doxyl but less quenched 
by 12-doxyl spin label. The position of this mutant would be suggested to reside deep 
in the membrane and close to inner bilayer surface than Trp 621 which can also be 
observed by maximum increase in Trp fluorescence as compared to other mutants. 
The fluorescence of other mutants was not directly quenched by doxyl-spin labels. 
Comparatively less quenching of an increased fluorescence induced by PC:PG 
(60:40%) vesicles was observed for Q581W and D611W by doxyl-spin labels. In 
addition, no change was observed for R601W. 
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FIG 4.7.2.1. Effect of doxyl-PC on fluorescence emission spectra of Trp mutants 
Q581W and E591W, respectively. Vesicles composed of 60% PC, 40% PG (dotted green 
lines) or 50% PC, 40% PG 10% doxyl-PC labeled at either 5- (red), or 12- (blue) position of 
the sn-2 acyl chain were prepared and mixed with mutant peptides (3 µM) in PBS, pH 7.4. 
The black lines show the corrected spectra in PBS (pH 7.4). All the spectra were corrected as 
described under “Experimental Procedures.” a.u., arbitrary units. 
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FIG 4.7.2.2. Effect of doxyl-PC on fluorescence emission spectra of Trp mutants 
R601W and D611W, respectively. Vesicles composed of 60% PC, 40% PG (dotted green 
lines) or 50% PC, 40% PG 10% doxyl-PC labeled at either 5- (red), or 12- (blue) position of 
the sn-2 acyl chain were prepared and mixed with mutant peptides (3 µM) in PBS, pH 7.4. 
The black lines show the corrected spectra in PBS (pH 7.4). All the spectra were corrected as 
described under “Experimental Procedures.” a.u., arbitrary units. 
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FIG 4.7.2.3. Effect of doxyl-PC on fluorescence emission spectra of Trp mutants 
E621W and L630W, respectively. Vesicles composed of 60% PC, 40% PG (dotted green 
lines) or 50% PC, 40% PG 10% doxyl-PC labeled at either 5- (red), or 12- (blue) position of 
the sn-2 acyl chain were prepared and mixed with mutant peptides (3 µM) in PBS, pH 7.4. 
The black lines show the corrected spectra in PBS (pH 7.4). All the spectra were corrected as 
described under “Experimental Procedures.” a.u., arbitrary units. 
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Table 4.7.2.  Fluorescence Quenching by Membrane-Embedded Doxyl-Spin Labels. 
 
All spectra from Figures 4.7.2.1-4.7.2.3 were integrated and normalized relative to the 
fluorescence obtained using lipid vesicles (PC:PG) lacking the doxyl-spin label. The percent 
quenching, relative to the total increase in fluorescence in the presence of PC:PG (60:40%) 
without nitroxide spin labels, is listed. 
 
Trp Mutants 
 
5-doxyl spin label 12-doxyl spin label 
Q581W 
 
14 12 
E591W 
 
4 2 
R601W 1 - 
D611W 9 3 
E621W 50 41 
L630W 
 
38 14 
 
 
 
4.7.3. Effect of Lipid Vesicles on Trp Accessibility to Collisional Quenching 
The calculated blue shifts of Trp mutants and quenching by membrane–embedded 
spin-labeled PC vesicles suggested that some parts of loop 13 might be embedded 
within the lipid bilayer. This was assessed in a more direct manner by means of 
acrylamide, a hydrophilic quencher of the Trp fluorescence. In addition, this quencher 
has the advantage that it has a very low permeability to lipid membranes.  
The Stern-Volmer quenching plots of each mutant in the absence and presence of 
phospholipid vesicles consisting of PC:PG (60:40%) were linear and are shown in 
Figure 4.7.3. The Stern-Volmer constants for all mutants are compiled in Table 4.7.3. 
It indicates that the Trp residues are more or less protected against quenching by 
acrylamide. As expected, Trp-621 and Trp-630 are completely protected. This 
supports their location in the lipid environment. Surprisingly, Trp-591 despite no 
interaction with the nitroxide quencher shows strong protection, suggesting an effect 
of lipid vesicles on folding of the peptide chain. Slight changes are also observed for 
Trp-581 and Trp-611, Trp-601 appears to be not affected.  
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FIG 4.7.3. Stern-Volmer plots of Trp fluorescence quenching by acrylamide.  
Quenching experiments were conducted as described under “Experimental Procedures.” In 
each panel the samples were investigated in the absence () and presence of ( ) 150 µM 
PC/PG (60:40 % molar ratios). The slopes of the best fit lines for each data set (KSV values) 
are shown in Table 4.7.3. Mean values ± standard deviation of two or three independent 
experiments are given.  
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Table 4.7.3. Stern-Volmer Constants of the Effect of PC:PG (60:40%) on Single-Trp 
Mutants of Loop 13 a 
Fluorescence parameters were determined from the data shown in Figure 4.7.3. 
 
Peptide DOPC:DOPG  
(60:40 %) b  
KSV c 
(M-1) 
Q581W - 
+ 
7.4 
4.5 
E591W - 
+ 
15.2 
2.5 
R601W - 
+ 
11.1 
10.6 
D611W - 
+ 
8.8 
5.4 
E621W - 
+ 
10.6 
1 
L630W 
 
- 
+ 
8.4 
1 
 
a Parameters of acrylamide accessibility were derived from the data shown in Figure 
4.7.3.  
b Quenching experiments were conducted in the absence (-) or presence (+) of 150 µM 
PC:PG (60:40%). 
c The Stern-Volmer constants were determined from the slopes of the linear regression 
lines from plots of F0/F = 1 + KSV [Q]. Values are mean ± standard deviation of two 
or three independent experiments. 
 
 
 
4.7.4. Effect of Lipid Composition on Trp Accessibility to Collisional Quenching 
 
In addition, the calculated quenching constants of each Trp accessibility in the 
absence and presence of 150 µM pure PC and PC:PG (70:30 %) are shown in Table 
4.7.4 (plots are not shown). The data shows that KSV values for all mutants in the 
presence of pure PC and PC:PG (70:30%) are significantly lower as compared to the 
KSV values in the presence of PC:PG (60:40%) vesicles. Thus, PC:PG (60:40%) 
vesicles are seem to favor the interaction and/or the orientation of loop 13 mutants 
more effectively with and/or within the membranes (see discussion). 
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Table 4.7.4. Influence of Lipid Composition of Vesicles on the Trp Fluorescence of 
Loop 13 Mutants. 
 
Stern-Volmer constants (M-1) for 3 µM of each Trp mutant in the absence and presence of 
vesicles (150 µM) of various compositions.  
 
Parameters of b and c were derived from acrylamide quenching data (not shown). 
 
Peptide No lipid a DOPC b DOPC:DOPG  
(70:30 %) c 
Q581W 7.4 6.6 n.d 
E591W 15.2 11.8 7.3 
R601W 11.1 13.4 11.4 
D611W 8.8 8.2 6.1 
E621W 10.6 11.0 1.5 
L630W 8.4 7.8 1.9 
a,b,c The Stern-Volmer constants were determined from the slopes of the linear regression 
lines from plots of F0/F = 1 + KSV  [Q] (Lackowicz, 1999). Values are mean ± 
standard deviation of two or three independent experiments. 
n.d Not determined 
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5. DISCUSSION 
 
5.1 Conformation of Loop 13  
 
The elucidation of structure-function relationship of membrane peptides has been 
hindered by difficulties in expressing the complete peptide. We, therefore, chose to 
express a fragment of SGLT1 supposed to function in the receptor region for the 
inhibitor phlorizin. Six different single Trp mutants of loop 13 were over-expressed 
using site directed mutagenesis to investigate the binding of phlorizin in detail. The 
use of truncated loop 13 (amino acid residues 564-638) compared to the previously 
used complete loop 13 was favored in order to introduce reporter molecules at 
different positions of the loop, to increase the solubility and to avoid complications by 
intrapeptide disulfide bridge formation between cysteine 560 and 608 residue (Xia et 
al., 2003). The truncation of the molecule did, however, not interfere with the ability 
of the peptide to interact with phlorizin. The phlorizin dissociation constants in our 
studies are very similar to those determined for the formation of the initial collision 
complex by Oulianova and Berteloot’s (1996) studies in intact membrane vesicles and 
also agree with the observed binding constant for complete loop 13 (Xia et al., 2003).  
To facilitate the discussion of the secondary structure of loop 13, the predicted 
conformation based on the amino acid sequence is shown in Figure 5.1. In agreement 
with this prediction the maxima of Trp fluorescence of the various mutants differ. For 
example mutants 581 and 591 show a spectrum which has a maximum close to 350 
nm, suggesting a random coil orientation of the neighbouring segments. For the other 
mutants e.g., 601, 611, 621 and 630, a more hydrophobic environment of the Trp can 
be assumed (blue shift of the maxima) suggesting a location in more ordered, 
probably α-helical structure (see Table 5.1). The presence of these α-helices in 
solution is confirmed by the CD spectrum that quite nicely reflects the relative 
abundance of the various conformations. 
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FIG. 5.1. A schematic two-dimensional model of loop 13 of SGLT1 (amino acid 
residues 564-638). Yellow stars, the positions of six single Trp mutations. Red residues, the 
predicted percentage of α-helices of domain. Only a single molecule with indicated positions 
of single Trp mutations is shown rather than six single-Trp mutants.  
 
 
 
 
Table 5.1. Properties of Trp Mutants of Loop 13 
 
Trp Mutants Local environment of Trp 
in buffer 
Positions of Trp residues in 
a peptide 
Q581W Hydrophilic  Random coil 
E591W Hydrophilic Random coil 
R601W Hydrophobic α-helix 
D611W Hydrophobic Random coil (located in 
between two α-helices) 
E621W Hydrophobic α-helix 
L630W Hydrophobic α-helix 
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5.2 Interaction of Phlorizin with Loop 13  
 
The strong sensitivity of Trp fluorescence intensity to peptide microenvironment is 
routinely exploited to follow a variety of protein conformational changes, e.g., 
ligand/substrate binding, folding/unfolding etc. (Callis and Vivian, 2003). The results 
of the studies with phlorizin are semi-quantitatively summarized in Table 5.2. Several 
major spectral changes are induced by phlorizin binding to loop 13. First, a red shift 
of the fluorescence maximum which indicates a transition between ordered 
(hydrophobic) to less ordered state of the loop (more hydrophilic). The most evident 
shift is observed for mutant D611W. Thus phlorizin binding appears to induce the 
opening of the region around amino acid 611 of loop 13, which before seems to be 
buried in between the two α-helices (see Figure 5.2 A).  
The shift of the maximum of Trp fluorescence towards longer wavelength 
could, however, also be caused by a strong interaction of phlorizin associated water 
with the loop. Such a complex between phlorizin and water molecules can be formed 
by H-bonding between OH groups of phlorizin (e.g., mainly by 4-OH and 6-OH 
group of ring A and 4-OH of ring B). This would suggest a position of D611 in the 
binding pocket. A critical role of this region of loop 13 in phlorizin binding has also 
been proposed from studies on the intact carrier using site directed mutagenesis 
(Novakova et al., 2001) and from the biophysical studies using isolated loop 13 in 
solution (Xia et al., 2003, Xia et al., 2004). 
The similar red shift in the fluorescence maximum of L630W is difficult to 
explain by the above assumption. Perhaps, in this part of loop 13, bound water 
molecules situated around the peptide contribute mostly to the signal. In other studies 
ligand induced conformational changes were also deduced from the fluorescence 
spectra. In this instance both water around the ligand and water around the peptide 
contributed to the shift, the contribution of each, in most cases, is difficult to estimate 
(Vivian and Callis, 2001).  
Furthermore, fluorescence quenching was observed. We would like to 
correlate the quenching with the proximity of the indol ring of Trp to the phlorizin 
molecule. The main mechanism responsible for fluorescence quenching is charge/ 
energy transfer between phlorizin and Trp residues. Similar effects were observed for 
collagen fluorescence in the presence of varying concentrations of hypericin (Yova et 
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al., 2002; Yova et al., 1999). The maximum fluorescence quenching at the 611 
position could then indicate that the phlorizin ring A is very close to the free indol 
ring of tryptophan. For the amino acids located in region 606-609 an interaction, 
although with slightly less affinity, would ensue. Thereby the binding site is defined. 
The minimum quenching observed for mutant L630W would suggest a positional 
arrangement of this part of loop far from the binding region. In case of mutants 
Q581W and E591W, significant quenching signals in the presence of phlorizin (see 
Table 5.2) might be attributed to a conformational change which brings this part of 
loop 13 somehow close to the binding site (see Figure 5.2 B). 
 
 
Table 5.2. Effect of Phlorizin on Trp Fluorescence Parameters of Loop 13 Mutants  
 
Trp Mutants Red shift of 
fluorescence maximum 
Quenching Acrylamide 
accessibility 
Q581W + ++ - 
E591W ++ ++ ++ 
R601W +++ +++ +++ 
D611W ++++ ++++ ++++ 
E621W +++ +++ +++ 
L630W +++ + - 
+ correlates to high values 
- correlates to low or non-significant values 
 
 
A surprising result of this study is that the region especially between 591-621 is more 
accessible to acrylamide in the presence of phlorizin than in its absence (see Table 
5.2). In our previous studies on phlorizin binding to loop 13 a protection effect of 
phlorizin was observed leading to a decreased accessibility of Trp at position 561 and 
its resonance partner Tyr at position 604 (Xia et al., 2003). The difference might be 
due to the fact, that in the former studies the peptide contained a disulfide bond which 
can alter the conformational changes significantly. The high accessibility of D611W 
towards acrylamide after phlorizin binding suggests that the interaction with phlorizin 
occurs in an aqueous environment; hence no protection effect is observed.  
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It is interesting to note that phloretin, the aglucone of phlorizin, induced 
qualitatively similar changes in D611W as phlorizin, although the effects on 
fluorescence and acrylamide accessibility were smaller. These results suggest that 
phloretin might bind to the same site as phlorizin. The larger disturbance of the 
conformation of loop 13 by phlorizin might be explained by the bulky nature of the 
glucose residue attached to the two aromatic rings. If phloretin indeed binds to the 
same site as phlorizin the non-competitive nature of the inhibition of D-glucose 
transport by phloretin might be due to a close coupling between loop 13 and the sugar 
translocating positions of SGLT1. Such coupling can occur by the formation of 
disulfide bonds between the extramembranous loops, direct evidence for the presence 
of such bonds has been obtained in our previous studies (Xia et al., unpublished 
results). In addition, we have also found ligand-induced conformational changes of 
SGLT1 in intact rabbit renal medullary brush-border membrane vesicles by 
monitoring the accessibility of extramembraneous cysteine residues with polyethylene 
oxide-maleimide activated biotin, followed by specific immunodetection of the biotin-
coupled peptide (Xiaobing and Kinne-unpublished data) and by determining binding 
probability and unbinding force using antibodies against loop 13 attached to an atomic 
force microscopic cantilever (Wielert-Badt et al., 2002). 
The conformation of phlorizin in aqueous solutions was previously studied by 
two-dimensional NMR and pharmacophore analysis by Wielert-Badt et al., 2000. 
Their model indicates that the interactions via hydrogen bonds from the 2-, 3-, 4-, and 
6-hydroxyl groups (OH) of the pyranoside and the 4- and 6-OH of the aromatic ring A 
are essential for phlorizin binding. This information can now be combined with the 
Trp fluorescence data to estimate the dimensions of the phlorizin recognition and 
binding region. We can assume that the phlorizin binds to the region very close to 
position 611 by H-bonding probably with the 4-OH group by acceptor/donor atom O4 
of the aromatic ring A. Thus, position 611 is supposed to be very important in 
phlorizin recognition as also suggested by the lower affinity of the D611W mutant. 
The H-bonding of any one hydrophobic amino acid residue located in 606-609 region 
with the 6-OH group by acceptor/donor atom O6 of the aromatic ring A of phlorizin 
also causes a strong interaction.  
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FIG. 5.2.  A, Schematic two-dimensional model of loop 13 of rabbit SGLT1 (amino 
acids 564-638). Left panel: Arrangement of amino acids in the absence of phlorizin. α-helical 
areas are based on computer program and hydrophobicity of the Trp environment, 
arrangement of random coil takes into account the hydrophilicity of the Trp environment as 
predicted from the fluorescence maxima. Right panel: yellow stars represent the Trp 
mutations, green represents the presumed phlorizin-binding region; the red arrow indicates 
the proposed position of phlorizin in the binding region and the blue arc highlights the main 
area of conformational changes. The exposure of the region around position 611 to a more 
hydrophilic environment is derived from the strong red shift of the Trp fluorescence 
maximum. B, three-dimensional conformation of phlorizin according to NMR studies by 
Wielert-Badt et al., 2000. The arrows show the interactions of the aromatic ring A and B 
with the binding region (Raja et al., 2003).  
 
 
B 
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On the basis of fluorescence studies of loop 13 in the presence of phlorizin, we 
could provide a generalized mechanism by which phlorizin inhibits sugar transport by 
SGLT1. According to our assumption, a phlorizin binding region in SGLT1 is located 
in between amino acids 601-611, in this region aromatic rings (A and B) of phlorizin 
interact with hydrophobic amino acids and the glucoside moiety of phlorizin is free to 
interact with sugar interaction sites of SGLT1 (Loo and Silverman, 1998; Diez-
Sampedro et al., 2001). Previous mutagenesis studies provided evidence that also 
Asp-176 might be involved in determining the overall affinity of phlorizin to the 
transporter (Panayotova et al., 1994). Thus, there seems to be a close vicinity between 
loop 13 and Asp-176, again probably caused by disulfide bonds between various parts 
of the transporter. 
According to our modeling assumptions based on secondary structure 
prediction and CD analysis, the regions especially between 599-607 and 620-631 
around the binding pocket are in α-helical conformation. In the absence of phlorizin 
the region around amino acid 611 appears to interact with a part of the α-helical 
region, in particular with the hydrophobic amino acid residues between 606-609. 
Upon phlorizin binding this region becomes exposed to aqueous environment as 
shown by direction of the big red arrow in Figure 5.2 A.  
In addition, the 4-OH group of the aromatic ring A comes close to position 
611 effecting the Trp emission strongly (see Figure 5.2 B). At the same time the 
aromatic ring B comes conformationally close to position 600. Such a position has 
been identified in photoaffinity labeling studies with 3-azidophlorizin (Raja et al., 
2003). We also propose that phlorizin binding results in reduction of van der Waals 
forces between parts of the two helices (e.g., interaction between 599-607 and 620-
629 α-helical residues) while some parts of the α-helix (e.g., that close to position 
630) are accessible to acrylamide irrespective of the presence of phlorizin.  
It is necessary to discriminate the differences between an intact SGLT1 and 
isolated domain to understand the mechanism of interaction of various transport 
inhibitors in vivo as well as in vitro. Mutagenesis studies performed on intact SGLT1 
showed that hydrophobic region (amino acid residues 604-610), located extracellulary 
in loop 13 are responsible for the interaction of phlorizin. In addition, the amino acids 
containing negative side chains affected the affinity of phlorizin drastically 
(Novakova et al., 2001). The experiments performed by over-expressing C-terminal 
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domain in vitro nicely reflected the changes in affinity of phlorizin to loop 13, as does 
the intact carrier. The specific method employed to observe conformational changes 
in an isolated loop 13 in the presence of phlorizin and the affinity of this domain are 
the major findings of the study presented here which could not be possible by using 
whole SGLT1. 
All peptides need a specific three-dimensional structure to perform their 
particular function. Keeping in mind the difficulties in resolving the structure of 
mammalian membrane peptides, in general, and in the case of SGLT1 in particular, 
the use of SGLT1 fragments appears to be advantageous to study their function in 
more detail by using different biophysical methods, although the refinement of the 
assumed conformation and dimensions of phlorizin binding sites during SGLT1-
inhibitor complex formation by NMR or x-ray crystallography is still required.  
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5.3. Interaction of Alkyl Glucosides with Loop 13 
 
We observed basically three different parameters for the Trp fluorescence when n-
hexyl-β-D-glucoside interacted with loop 13: (I) spectral shift in the fluorescence 
maximum, (II) fluorescence quenching, and (III) acrylamide accessibility. The 
changes observed are summarized semi quantitatively in Table 5.3. Since the affinity 
of n-hexyl-β-D-glucoside for the different mutants of loop 13 is quite similar, the 
differences in parameters I and III are interpreted as an indication of different 
conformational changes in different portions of loop 13. The quenching we notice in 
this study is probably due to positioning of the Trp molecule in the proximity of 
methionine, tyrosine, threonine, arginine, and/or lysine (Zhao and Kinnunen, 2002; 
Breukink et al., 1998) since the ligand n-hexyl-β-D-glucoside is spectroscopically 
silent. The protection against acrylamide is interpreted as a reduced accessibility of 
Trp caused by the fact that either the alkyl glucosides or a part of the loop shields Trp 
against the collision with acrylamide. 
 
Table 5.3. Effect of n-Hexyl-β-D-glucoside on Trp Fluorescence Parameters of Loop 
13 Mutants  
 
Trp Mutants Quenching  Spectral shifts  Acrylamide 
accessibility 
Q581W + No change - 
E591W No change No change - 
R601W +++ Blue shift - - - - 
(Strong decrease) 
D611W ++++ Blue shift - - 
(Decrease) 
E621W +++++ Red shift + 
(Increase) 
L630W +++ Strong blue shift - - 
(Decrease) 
+ correlates to high values 
- correlates to low values 
 
 
The changes in the fluorescence of the various regions can be explained by the 
following events. For Q581W and E591W mutants, we did not observe significant 
changes suggesting that these positions do not participate in the interaction between 
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loop 13 and n-hexyl-β-D-glucoside (see Table 5.3). In a way, this is to be expected 
since computer modeling suggests a random orientation of this part of loop 13 (Raja 
et al., 2003 or under section 5.1).  
The changes discussed below are compiled in the schematic model presented 
in Figure 5.3. For R601W, we observe a small blue shift in the maximum, a minor 
quenching, but maximum protection against acrylamide. The protection is probably 
caused by a strong binding of part of the alkyl glucoside in this area as also found in 
the photoaffinity labeling experiments where a direct interaction of the C2 position of 
the alkyl side chain with amino acids 598-601 could be demonstrated. The slight blue 
shift i.e., increase in hydrophilicity of the environment supports the assumption that 
the alkyl side chain is the part of the glucoside, which is binding. The experiments 
with 1-hexanol, where identical changes in the fluorescence of R601W were observed 
for 1-hexanol and n-hexyl-β-D-glucoside, point in the same direction.  
The major change found for D611W is a strong quenching of fluorescence 
upon interaction with n-hexyl-β-D-glucoside. These data indicate that this area of loop 
13 changes its position significantly with regard to neighboring areas of loop 13 but 
maintains its accessibility to acrylamide. The nearest neighbours responsible for major 
quenching could be the arginines at positions 601 and 602 or a methionine at position 
618. Such a movement would require a high flexibility of this part of the molecule 
which is actually predicted by modeling, since this region is located in a random coil 
(Raja et al., 2003) between two helices (Raja et al., 2004, see also Figure 5.3).  
E621W exhibits strong quenching and increased accessibility to acrylamide 
upon interaction with n-hexyl-β-D-glucoside. This probably also reflects the 
movement of the randomly coiled part of loop 13, although the specific interactions 
cannot be delineated currently with the data at hand. L630W exhibits the most 
prominent blue shift in the fluorescence maximum and a strong quenching by n-
hexyl-β-D-glucoside. Thus, major changes occur in this region of loop 13. A more 
condensed state of the molecule that positions Trp 630 close to the helical 
(hydrophobic) part between amino acids 599 and 607 could explain both effects. 
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FIG. 5.3. Schematic two-dimensional model of n-hexyl-β-D-glucoside binding to 
the part of loop 13 of rabbit SGLT1.  Red residues represent the assumed (hydrophobic 
sites of interaction between loop 13 and n-hexyl-β-D-glucoside. Yellow stars indicate single 
Trp mutations. C2 of the alkyl side chain is supposed to bind to the region between amino 
acids 598-601, C4 to 615-616 amino acid residues and C6 to the region between 621 to 630 
amino acids. For further information see also previous studies (Raja et al., 2003 or under 
section 5.1). 
 
The proposed model can be compared to the schematic two-dimensional 
model presented recently for the interaction between phlorizin and loop 13 (see under 
section 5.1). There, phlorizin unfolds the segment of loop 13 between amino acid 
residues 608 and 620; n-hexyl-β-D-glucoside on the other hand appears to condense 
loop 13 and buries this segment between the two putative small helices. This 
assumption is supported by the observation that in additional fluorescence quenching 
studies n-hexyl-β-D-glucoside prevents phlorizin from interacting with loop 13 (data 
not shown).  
Thus, irrespective of the model assumed, it is clear that n-hexyl-β-D-glucoside 
interacts with loop 13. Interestingly, this interaction is quite strong, and the apparent 
affinities are close to those observed for the inhibition of D-glucose transport by the 
intact SGLT1 in natural membranes (Kipp et al., 1997). In addition, the relative 
potencies of the α- and β-glucosides and cis and trans derivatives of hexenyl 
glucosides on the transporter and in the isolated loop are comparable (Kipp et al., 
1996). These results support the view that loop 13 contains structural elements that 
mimic the conditions prevailing in the intact SGLT1. 
C2
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However, a word of caution is also necessary. There is a discrepancy between 
the results obtained for intact membrane-bound SGLT1 and study of an isolated 
loop13 with regard to the effect of chain length of alkyl glucosides on binding. In this 
study, strong binding was observed for a chain length of six to eight carbons, whereas 
inhibition of D-glucose transport was maximal with a chain length of 10 carbons in 
the alkyl side chain (Kipp et al., 1996). This observation might suggest that in the 
intact SGLT1 other parts of the transporter also interact with alkyl glucosides. 
However, it is also possible that the conformation of the peptides used here and that of 
loop 13 in the intact carrier is different. The truncation of loop 13 removes the 
cysteine at position 560 which can form a disulfide bridge and thus alter the 
conformation in vivo. One additional site of interaction, most probably for the glucose 
part of alkyl glucoside, is the sugar binding site of the transporter, which is similar to 
the observation with phlorizin (Frasch et al., 1970). This interaction predominates in 
the inhibition kinetics of the transport which is evident from the competition of D-
glucose and n-hexyl-β-D-glucoside in the uptake studies. 
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5.4. Interaction of Loop 13 with Lipid Vesicles 
 
For all mutants except 601, an increase in Trp fluorescence and blue shift in 
maximum was observed upon addition of negatively charged lipids which indicates 
the transfer of Trp residues from an aqueous to a hydrophobic environment (Breukink 
et al., 1998; Macek et al., 1995). The changes in the fluorescence observed for the 
various mutants after association with lipid vesicles are summarized in Table 5.4. 
 
Table 5.4. Effect of Lipid Vesicles on Trp Fluorescence Parameters of Loop 13 
Mutants  
 
Peptide Fluorescence  Blue shifts in 
maxima  
Spin label 
proximity  
Acrylamide 
accessibility  
Positioning in 
bilayer  
Q581W Increase  Very strong 
shift 
Low  Decrease 
 
Yes 
E591W Increase 
 
Slight shift None  Maximum 
decrease 
No 
R601W No change No change None No change No 
D611W Increase 
 
Slight shift Low  Decrease No 
E621W Increase 
 
Strong shift Present  Complete 
decrease  
Yes 
L630W Max. 
Increase  
Strong shift Present  Complete 
decrease 
Yes 
 
Interestingly these changes were not observed when pure PC vesicles were 
used. Since loop 13 contains several positively charged amino acids an interaction 
with the negatively charged head groups of PG is necessary for the association of the 
peptide to the lipids. The findings that in the presence of 30% PG less protection of 
each single Trp against acrylamide was observed than in the presence of 40% PG are 
consistent with this assumption.  
As another major change, blue shifts in the maxima were observed. These 
indicate the positioning of the tryptophan into a more hydrophobic environment. In 
the experimental system employed here, this effect might be caused by insertion into 
the acyl side chains of the lipid phase of the phospholipids or due to a change in 
peptide conformation or both. We tested for the insertion into the lipid phase by 
employing doxyl labeled phospholipids and we now compare the two parameters.  
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For Q581W, we observed a very strong blue shift in the maximum and slight 
fluorescence quenching by doxyl groups. It thus can be assumed that this residue 
resides in the bilayer (see model in Figure 5.4). The significant protection against 
acrylamide in the presence of lipid vesicles also points in this direction. The 
discrepancy between the large change in the spectral maximum and the relative 
moderate effect of the doxyl quenchers can be explained by the fact that in the 
absence of the lipids Trp-581 resides in a very hydrophilic environment. The insertion 
into the hydrophobic lipids therefore causes the large blue shift. 
E591W exhibits only a small blue shift, no quenching by doxyl derivations 
and maximum protection against acrylamide upon addition of lipid vesicles. 
Conformational changes of the peptide, such as positioning of one helix above the 
Trp-591 could result in a blue shift and maximum protection of this Trp against 
acrylamide. 
Surprisingly, no significant change in parameters of Trp fluorescence was 
observed for R601W in the presence of vesicles, thus, this part of the peptide appears 
not be involved in interaction with the membrane. The positively charged poly lysine 
residues from position 594 to 597 strongly interact with the negatively charged polar 
head groups of the phospholipids, which form a major attachment site of the peptide. 
Studies performed by atomic force microscopy on lipid-peptide interaction suggest a 
similar situation (Wimmer et al., unpublished data; see also model in Figure 5.4). 
For position 621 and 630 the strong blue shift in maxima and the quenching by 
doxyl labels strongly suggest immersion of this region into the acyl side chains of the 
phospholipids. The position of Trp-621 is probably closer to the center of the lipid 
bilayer than that of Trp-630 because the doxyl label at C5 and C12 quench the 
tryptophan fluorescence to the same extent in 621 where the effect of the label at C5 
is stronger for Trp 630 (see model in Figure 5.4). This conclusion is also supported by 
the fact that both tryptophan residues become completely inaccessible to acrylamide 
and that this part of the peptide is also predicted to form a short hydrophobic α-helix. 
The reinsertion of the loop pulls 611 close to the membrane as evidenced by the 
decreased accessibility to acrylamide. 
 
  Discussion 
 
   
  59
 
  
 
 
 
FIG. 5.4. Proposed two-dimensional model of the organization of Trp residues of 
Loop 13 in lipid vesicles. Trp residues at different positions are shown in red as aromatic 
rings with indol side chain. Upper panel: peptide conformation as depicted (Raja et al., 2003) 
in the absence of lipid vesicles, Lower panel: A conformation of the peptide assumed with 
Trp residues (red) in a lipid bilayer as suggested by the changes in Trp fluorescence 
parameters. Poly lysine region is also shown in a form of positive charges. 
 
 
 
The topology of loop 13 in artificial membranes cannot assign the position of 
the early part of loop 13 studied here (amino acid residues 564-580) either inside or 
outside of the vesicles since no experimental data are available. The early parts of 
loop 13 also contain phosphorylation motifs for protein kinases at 562 position 
(Hediger et al., 1987) that in order to be physiologically relevant have to be exposed 
to the cytoplasm. A verification of an extramembranous orientation of late part of 
Membrane outer surface
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loop 13 (amino acid residues 606-630) was studied by Wielert-Badt et al., 2002, by 
using molecular recognition atomic force microscopy on membrane vesicles. In 
addition to these studies, the findings are also consistent with the location of loop 13 
which strongly reacts with an antibody, raised against amino acid residues 606-630, 
from outside of an intact SGLT1 (Lin et al., 1999).  
In the present study, the topology of loop 13 in the membrane is consistent 
with the observations of in vitro as well as in vivo studies where phlorizin and alkyl 
glucosides interact with the hydrophobic parts of the transporter which were found on 
loop 13 (Novakova et al., 2001; Xia et al., 2003; Raja et al., 2003). The regions 600 
to 611 as a phlorizin binding pocket and between 601 to 619 which contain binding 
sites for alkyl glucosides should be located extracellulary to provide interaction sites 
on SGLT1. Furthermore, the region 621 to 630 which is exposed to lipid bilayer phase 
in our fluorescence quenching studies contains another alkyl glucoside interaction 
region. Thus, the interaction of an alkyl side chain of an alkyl glucoside with the 
region in between 621 to 630 (predicted to be located in α-helical region) of loop 13 
in a hydrophobic environment of lipid bilayer is most likely to be favored.  
 
 
 
 
   
 
   
  61
 
  
 
 
6. SUMMARY 
 
 
SGLT1, a plasma membrane sodium/glucose cotransporter, is strongly inhibited by 
aromatic and aliphatic glucosides such as phlorizin and n-hexyl glucoside. We 
expressed a domain (loop 13), postulated to be involved in inhibitor binding, and 
labeled it with tryptophan reporter groups. Wild type and six mutants (Q581W, 
E591W, R601W, D611W, E621W and L630W) of loop 13 (amino acid residues 564-
638) were expressed in Escherichia coli and purified to homogeneity. Changes in Trp 
quenching and positions of the emission maxima were determined in order to 
determine the conformational changes occurring during inhibitor binding.  
After addition of phlorizin D611W displayed the largest quenching of 80%, 
followed by R601W (67%). It also exhibited the maximum red shift in Trp 
fluorescence (∼14 nm), indicating an exposure of this region to a more hydrophilic 
environment. Titration experiments performed for each mutant showed a similar 
phlorizin affinity for all mutants. Also the maximum change in the collisional 
quenching constant by acrylamide was noted for D611W (KSV = 11 M-1 in the absence 
of phlorizin and 55 M-1 in its presence). Similar results were obtained with phloretin. 
CD measurements and computer modeling revealed that D611W is positioned in a 
random coil situated between two α-helical segments. Taken together, these data 
indicate that phlorizin binding elicits changes in conformation leading to an ‘opening’ 
of loop 13. Modeling suggests an interaction of the 4- and 6-OH of the aromatic ring 
A of phlorizin with the region between amino acids 606 and 611. Phloretin seems to 
interact with the same region of the peptide. No quenching or protection was found 
for D-glucose. 
Alkyl glucosides are also competitive inhibitors of the transport. Therefore, we 
searched for potential binding sites for alkyl glucosides in loop 13. To this end, we 
used a photoaffinity label (2′-Azi-n-octyl)-β-D-glucoside and analysed the region of 
attachment using MALDI-mass spectrometry producing wild type recombinant loop 
13. Furthermore, experiments were conducted on single Trp mutants of loop 13 
(Q581W, E591W, R601W, D611W, E621W and L630W) to determine the changes in 
fluorescence in the presence of alkyl glucosides, and accessibility of each Trp mutant 
to acrylamide. Photolabeling of loop 13 with (2′-Azi-n-octyl)-β-D-glucoside revealed 
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an attachment of the C2 group of the alkyl chain to Gly-Phe-Phe-Arg (amino acid 
residues 598-601). In the presence of n-hexyl-β-D-glucoside the mutants (R601W, 
D611W, E621W and L630W) showed a significant decrease in Trp fluorescence with 
an apparent binding affinity of 8-14 µM. Only L630W showed a significant blue shift 
and only in R601W was a change in acrylamide quenching (protection) observed. 1-
hexanol produced the same results as n-hexyl-β-D-glucoside. The interaction shows 
stereo-selectivity for n-hexyl-β-D-glucoside binding; the β-configuration of the sugar 
moiety at C1, the cis-conformation of unsaturated alkenyl side chain at C3-C4, and 
the alkyl chain length of six to eight carbon atoms lead to an optimum interaction. A 
schematic two-dimensional model was derived in which C2 of the alkyl chain 
interacts with the region around residue 601, C3 and C4 interact with the region 
between residue 614 and 619, and C6-C8 interact with the region between residues 
621 and 630.  
The data demonstrate that loop 13 provides binding sites for alkyl glucosides 
as well as for phlorizin; but the regions of the peptide affected and the conformation 
assumed differ markedly. Thus, loop 13 of SGLT1 seems to be a major binding 
domain for the aglucone residues of competitive D-glucose transport inhibitors.  
Furthermore, the interaction of loop 13 with lipid vesicles was monitored by 
reconstitution experiments of all Trp mutants of loop 13. An increase in Trp 
fluorescence, blue shifts in maxima and protection against acrylamide to a certain 
extent were observed for each mutant, except for R601W, which exhibited no change 
in these parameters. Mutants Q581W, E621W, and L630W exhibited a strong blue 
shift, suggesting their position in the lipid bilayer. By using membrane-embedded 
doxyl spin labels at 5- and 12-position of acyl side chain this position was confirmed 
by the quenching of these tryptophans. The protection of Q581W, E621W, and 
L630W against acrylamide supported the assumption that these parts of loop 13 are 
inserted into lipid vesicles. The other parts of the peptide appear to remain outside the 
lipid bilayer; the four lysine residues from position 594 to 597 forming an attachment 
site to negatively charged phospholipids. This attachment is a prerequisite for the 
insertion of parts of the peptide into the membranes since fluorescence changes were 
only observed in lipid vesicles containing phosphatidylglycerol (PG).  
These studies thus reveal within one domain two different binding sites for 
inhibitors of the sodium-D-glucose cotransporter (SGLT1) which might act as targets 
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for the development of potential therapeutics to control sugar uptake in the intestine 
and kidney. 
The topology studies confirm that the phlorizin binding domain between 
amino acid residues 601 to 611 and the alkyl glucoside binding domain between 
amino acid residues 601 to 619 reside outside the lipid bilayer and in vesicles is freely 
accessible to the inhibitor. For the alkyl glucosides additional interactions with the 
lipid bilayers appear to occur. 
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7. ABBREVIATIONS: 
 
Arg   Arginine 
BBMV   Brush border membrane vesicles  
BisTris 2-[bis(2-hydroxyethyl)amino]-2-(hydroxymethyl)propane-1,3-diol 
CD  Circular dichroism 
cDNA Complementary deoxyribonucleic acid 
DNA Deoxyribonucleic acid 
dNTP Deoxynucleotide triphosphate 
Gln   Glutamine 
Gly   Glycine 
GST   Glutathione S-transferase 
His   Histidine 
Kd   Equilibrium dissociation constant 
Ki Inhibition constant 
Km Michaelis constant 
KSV   Collisional quenching constant 
MALDI-TOF   Matrix-assisted laser desorption ionisation-time of flight 
NMR Nuclear Magnetic Resonance 
PBS   Phosphate-buffered saline 
Phe   Phenylalanine 
rpm Rotations per minute 
SDS-PAGE  Sodium dodecylsulfate polyacrylamide gel electrophoresis 
SGLT1   Na+/D- glucose cotransporter  
Thr   Threonine 
Trp   Tryptophan 
Tyr   Tyrosine 
UV Ultraviolet 
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